T1	Disease 28 41	Breast cancer
#1	AnnotatorNotes T1	DOID:1612
T10	Collection 489 524	Arg658*, p.Gln1701*, and p.Arg1931*
T11	Variant 498 508	p.Gln1701*
T12	Variant 514 524	p.Arg1931*
T13	Disease 546 559	breast cancer
T15	Drug 826 839	diepoxybutane
T16	Drug 843 851	olaparib
T17	Variant 876 885	p.Arg658*
T2	Biomarker 104 188	Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2
T20	Disease 924 943	ER-negative disease
#7	AnnotatorNotes T20	DOID:0060076
T21	Disease 948 952	TNBC
T22	Variant 1099 1108	p.Arg658*
T26	Disease 1166 1191	ER-negative breast cancer
#11	AnnotatorNotes T26	DOID:0060076
T27	Variant 1355 1364	p.Arg658*
T3	Disease 209 222	breast cancer
#12	AnnotatorNotes T3	DOID:1612
T30	Variant 1470 1479	p.Arg658*
T31	Variant 1484 1494	p.Arg1931*
T32	Disease 1516 1536	ER-negative and TNBC
#13	AnnotatorNotes T32	DOID:0060076,DOID:0060081
T35	Disease 1614 1627	breast cancer
T36	Disease 1764 1787	FANCM-associated tumors
#16	AnnotatorNotes T36	not found
T4	Disease 296 309	breast cancer
T6	Disease 360 405	ER-negative and triple-negative breast cancer
#18	AnnotatorNotes T6	DOID:0060076,DOID:0060081
T8	Disease 407 411	TNBC
T9	Variant 487 496	p.Arg658*
T37	Biomarker 82 102	genetic risk factors
R1	Association Arg1:T37 Arg2:T1	
T38	Gene-Protein 153 158	BRCA1
T39	Gene-Protein 160 165	BRCA2
T40	Gene-Protein 167 172	PALB2
T41	Gene-Protein 174 177	ATM
T42	Gene-Protein 183 188	CHEK2
R2	Risk-Factor Arg1:T2 Arg2:T3	
T43	Gene-Protein 229 234	FANCM
T7	Gene-Protein 645 650	BRCA1
T5	Gene-Protein 481 486	FANCM
R3	Variant-Of Arg1:T5 Arg2:T10	
#2	AnnotatorNotes T8	DOID:0060081
#3	AnnotatorNotes T9	p.Arg658Ter
T14	Gene-Protein 360 362	ER
#4	AnnotatorNotes T11	p.Gln1701Ter
T45	Gene-Protein 654 659	BRCA2
#5	AnnotatorNotes T12	p.Arg1931Ter
T46	Gene-Protein 763 768	FANCM
#6	AnnotatorNotes T15	C007366
#8	AnnotatorNotes T16	CHEMBL521686
T18	Gene-Protein 870 875	FANCM
R4	Variant-Of Arg1:T18 Arg2:T17	
T19	Collection 924 952	ER-negative disease and TNBC
T47	Gene-Protein 1093 1098	FANCM
T24	Variant 1135 1145	p.Arg1931*
T25	Gene-Protein 1129 1134	FANCM
R5	Variant-Of Arg1:T47 Arg2:T22	
R6	Variant-Of Arg1:T25 Arg2:T24	
T23	Collection 1093 1145	FANCM:p.Arg658* and found that also FANCM:p.Arg1931*
R7	Risk-Factor Arg1:T23 Arg2:T26	
T28	Gene-Protein 1349 1354	FANCM
R8	Variant-Of Arg1:T28 Arg2:T27	
T29	Gene-Protein 1443 1448	FANCM
T34	Collection 1470 1494	p.Arg658* and p.Arg1931*
R9	Variant-Of Arg1:T29 Arg2:T34	
T48	Collection 1516 1536	ER-negative and TNBC
R10	Risk-Factor Arg1:T34 Arg2:T48	
T33	Drug 1695 1703	olaparib
R11	Response Arg1:T33 Arg2:T36	
R12	Risk-Factor Arg1:T17 Arg2:T19	
#9	AnnotatorNotes T14	HGNC:3467
T49	Gene-Protein 924 926	ER
T50	Gene-Protein 1516 1518	ER
T51	Gene-Protein 1764 1769	FANCM
T52	Gene-Protein 1166 1168	ER
A1	Loss-of-funtion T27
A2	Loss-of-funtion T30
A3	Loss-of-funtion T31
#10	AnnotatorNotes T38	HGNC:1100
#14	AnnotatorNotes T39	HGNC:1101
#15	AnnotatorNotes T40	HGNC:26144
#17	AnnotatorNotes T41	HGNC:795
#19	AnnotatorNotes T42	HGNC:16627
#20	AnnotatorNotes T43	HGNC:23168
T44	Biomarker 229 234	FANCM
#21	AnnotatorNotes T44	C518295
T53	Collection 296 405	breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer
R13	Risk-Factor Arg1:T44 Arg2:T53	
A4	Loss-of-funtion T9
A5	Loss-of-funtion T11
A6	Loss-of-funtion T12
